BCYC vs WFC · rev $1.5M vs P/E 15, rev $22.62B
Bicycle Therapeutics Ltd (BCYC) versus Wells Fargo & Company (WFC) — a side-by-side from cached financials, not a winner call.
Bicycle Therapeutics Ltd (BCYC) is a biotechnology company listed on US.
Wells Fargo & Company (WFC) is a banks - diversified company listed on US. It is led by Charlie Scharf.
Latest reported BCYC revenue for 2026-06-30 was $1.5M. Net income was -$111.2M. Revenue was up 70.9% from 2026-03-31 to 2026-06-30. BCYC currently screens at market cap $554.0M.
Latest reported WFC revenue for 2026-06-30 was $22.62B. Net income was $6.41B. Revenue was up 5.5% from 2026-03-31 to 2026-06-30. WFC currently screens at market cap $272.05B and trailing P/E 15.0.
BCYC currently screens at market cap $554.0M. WFC currently screens at market cap $272.05B and trailing P/E 15.0.
Not investment advice. Open the BCYC and WFC stock pages for the full models.
Not investment advice.